Transaction in Own Shares
Summary by AI BETAClose X
LEGAL & GENERAL GROUP PLC
ISIN: GB0005603997
3rd August 2026
LEI number: 213800JH9QQWHLO99821
Legal & General Group Plc (the "Company")
Transaction in Own Shares
The Company announces that from 27th July 2026 up to and including 31st July 2026 it had purchased a total of 1,749,021 of its ordinary shares of 2.5 pence each (the "ordinary shares"), through the Company's broker Barclays Capital Securities Limited as detailed below. The repurchased ordinary shares will be cancelled.
|
Date |
Aggregate number of ordinary shares purchased |
Highest price paid (per ordinary share) |
Lowest price paid (per ordinary share) |
Volume weighted average price
|
Trading venue |
|
27th July 2026 |
349,021 |
302.30 |
297.20 |
299.03 |
XLON |
|
28th July 2026 |
87,242 |
299.00 |
294.90 |
296.85 |
XLON |
|
28th July 2026 |
94,240 |
298.50 |
294.90 |
296.15 |
BATE |
|
28th July 2026 |
73,807 |
298.90 |
294.90 |
296.43 |
TRQX |
|
28th July 2026 |
12,480 |
297.90 |
295.20 |
296.55 |
AQXE |
|
28th July 2026 |
82,231 |
298.90 |
294.90 |
296.54 |
CHIX |
|
29th July 2026 |
40,458 |
299.60 |
294.90 |
296.22 |
XLON |
|
29th July 2026 |
99,578 |
299.20 |
294.40 |
295.84 |
BATE |
|
29th July 2026 |
89,209 |
298.40 |
294.50 |
295.67 |
TRQX |
|
29th July 2026 |
10,906 |
296.60 |
294.60 |
295.67 |
AQXE |
|
29th July 2026 |
109,849 |
299.60 |
294.30 |
296.00 |
CHIX |
|
30th July 2026 |
57,756 |
301.50 |
295.10 |
299.39 |
XLON |
|
30th July 2026 |
99,740 |
301.40 |
296.80 |
299.32 |
BATE |
|
30th July 2026 |
89,097 |
301.30 |
295.20 |
298.92 |
TRQX |
|
30th July 2026 |
11,037 |
299.10 |
297.10 |
298.19 |
AQXE |
|
30th July 2026 |
92,370 |
301.10 |
295.10 |
298.70 |
CHIX |
|
31st July 2026 |
53,078 |
302.80 |
299.70 |
301.19 |
XLON |
|
31st July 2026 |
89,374 |
302.80 |
299.70 |
301.36 |
BATE |
|
31st July 2026 |
82,061 |
302.80 |
299.70 |
301.49 |
TRQX |
|
31st July 2026 |
23,948 |
302.70 |
300.40 |
301.20 |
AQXE |
|
31st July 2026 |
101,539 |
302.80 |
300.40 |
301.65 |
CHIX |
The purchases form part of the Company's share buyback programme announced on 11th March 2026.
Following settlement of the above purchases and cancellation of the purchased ordinary shares, the Company's total number of ordinary shares in issue shall be 5,527,346,046 ordinary shares.
No ordinary shares are held in treasury. Therefore, the total number of voting rights in the Company is 5,527,346,046.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as incorporated into and implemented under English law (including by virtue of the European Union (Withdrawal) Act 2018), the detailed breakdown of individual trades made by Barclays Capital Securities Limited on behalf of the Company as part of the share buyback programme is set out below.
http://www.rns-pdf.londonstockexchange.com/rns/9768O_1-2026-8-3.pdf
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 3 hours ago RIT Capital Partners
- 3 hours ago Legal & General Group
- 3 hours ago BioPharma Credit
- 4 hours ago BioPharma Credit
- 4 hours ago Great Portland Estates